ZINNAT 125 mg/5 ml for children and for infants, granules for oral suspension in a vial bottle, 50 ml
Active ingredients: Cefuroxime, Cefuroxime axetil
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINNAT 125 mg/5 ml ENFANTS ET NOURRISSONS, granulés pour suspension buvable en flacon
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon en verre jaune(brun) de 50 ml de suspension buvable reconstituée avec seringue doseuse pour administration orale de 5 ml
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61068069CIP73340334CIP133400933403348Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME AXÉTILgranulés | 150 mg · 5 ml de suspension reconstituée | SA |
| CÉFUROXIMEgranulés | 125 mg · 5 ml de suspension reconstituée | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.